<p>Gene therapy offers many conceptual advantages to treat muscle diseases, especially various forms of muscular dystrophies; however, it faces a number of unique challenges, including the need to deliver a therapeutic vector to all muscles throughout the body. In Muscle Gene Therapy: Methods and Pr
Retinal Gene Therapy: Methods and Protocols
β Scribed by Camiel J.F. Boon,Jan Wijnholds (eds.)
- Publisher
- Humana Press
- Year
- 2018
- Tongue
- English
- Leaves
- 373
- Series
- Methods in Molecular Biology 1715
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
This detailed volume describes a spectrum of methods and protocols that can be used for the bench-to-bedside development and evaluation of retinal gene therapy. Methods for the successful delivery of these gene therapy vector systems to the retina are examined, as well as assays to test the efficacy in vitro in cell cultures, for gene augmentation and gene editing in vivo on rodents, pigs, and monkey retinas, and on human retinal explants as well as in human clinical studies. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible protocols, and tips on troubleshooting and avoiding known pitfalls.
Authoritative and practical, Retinal Gene Therapy: Methods and Protocols provides a wide range of readers from students to research experts with vital information on ocular gene therapy vector technology, in vitro and in vivo biological assays, and clinical protocols, to promote further studies for the benefit of children and adults with inherited retinal disease.
β¦ Table of Contents
Front Matter ....Pages i-xvi
Front Matter ....Pages 1-1
Small Scale Production of Recombinant Adeno-Associated Viral Vectors for Gene Delivery to the Nervous System (Joost Verhaagen, Barbara Hobo, Erich M. E. Ehlert, Ruben Eggers, Joanna A. Korecka, Stefan A. Hoyng et al.)....Pages 3-17
Small and Micro-Scale Recombinant Adeno-Associated Virus Production and Purification for Ocular Gene Therapy Applications (Christopher A. Reid, Daniel M. Lipinski)....Pages 19-31
Design and Development of AAV-based Gene Supplementation Therapies for Achromatopsia and Retinitis Pigmentosa (Christian SchΓΆn, Elvir Becirovic, Martin Biel, Stylianos Michalakis)....Pages 33-46
Development of Multigenic Lentiviral Vectors for Cell-Specific Expression of Antiangiogenic miRNAs and Protein Factors (Anne Louise Askou, Thomas J. Corydon)....Pages 47-60
Design and In Vitro Use of Antisense Oligonucleotides to Correct Pre-mRNA Splicing Defects in Inherited Retinal Dystrophies (Alejandro Garanto, Rob W. J. Collin)....Pages 61-78
Three-Dimensional Co-Culture Bioassay for Screening of Retinal Gene Delivery Systems (Ding Wen Chen, Kathleen Pauloff, Marianna Foldvari)....Pages 79-88
Retinal Gene Therapy for Choroideremia: In Vitro Testing for Gene Augmentation Using an Adeno-Associated Viral (AAV) Vector (Maria I. PatrΓcio, Robert E. MacLaren)....Pages 89-97
Front Matter ....Pages 99-99
In Vivo Electroporation of Developing Mouse Retina (Jimmy de Melo, Seth Blackshaw)....Pages 101-111
Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina (Sandy S. Hung, Fan Li, Jiang-Hui Wang, Anna E. King, Bang V. Bui, Guei-Sheung Liu et al.)....Pages 113-133
AAV Gene Augmentation Therapy for CRB1-Associated Retinitis Pigmentosa (C. Henrique Alves, Jan Wijnholds)....Pages 135-151
Dual AAV Vectors for Stargardt Disease (Ivana Trapani)....Pages 153-175
Optogenetic Retinal Gene Therapy with the Light Gated GPCR Vertebrate Rhodopsin (Benjamin M. Gaub, Michael H. Berry, Meike Visel, Amy Holt, Ehud Y. Isacoff, John G. Flannery)....Pages 177-189
CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa: A Brief Methodology (Wen-Hsuan Wu, Yi-Ting Tsai, Sally Justus, Galaxy Y. Cho, Jesse D. Sengillo, Yu Xu et al.)....Pages 191-205
In-Depth Functional Analysis of Rodents by Full-Field Electroretinography (Vithiyanjali Sothilingam, Regine MΓΌhlfriedel, Naoyuki Tanimoto, Mathias W. Seeliger)....Pages 207-213
Advanced Ocular Injection Techniques for Therapy Approaches (Regine MΓΌhlfriedel, Marina Garcia Garrido, Christine Wallrapp, Mathias W. Seeliger)....Pages 215-223
Neutralizing Antibodies Against Adeno-Associated Virus (AAV): Measurement and Influence on Retinal Gene Delivery (MΓ©lissa Desrosiers, Deniz Dalkara)....Pages 225-238
Screening for Neutralizing Antibodies Against Natural and Engineered AAV Capsids in Nonhuman Primate Retinas (Timothy P. Day, Leah C. Byrne, John G. Flannery, David V. Schaffer)....Pages 239-249
Subretinal and Intravitreal Retinal Injections in Monkeys (Daniyar Dauletbekov, K. Ulrich Bartz-Schmidt, M. Dominik Fischer)....Pages 251-257
Front Matter ....Pages 259-259
Production of iPS-Derived Human Retinal Organoids for Use in Transgene Expression Assays (Peter M. Quinn, Thilo M. Buck, Charlotte Ohonin, Harald M. M. Mikkers, Jan Wijnholds)....Pages 261-273
AAV Serotype Testing on Cultured Human Donor Retinal Explants (Thilo M. Buck, Lucie P. Pellissier, Rogier M. Vos, Elon H. C. van Dijk, Camiel J. F. Boon, Jan Wijnholds)....Pages 275-288
Human Retinal Explant Culture for Ex Vivo Validation of AAV Gene Therapy (Harry O. Orlans, Thomas L. Edwards, Samantha R. De Silva, Maria I. PatrΓcio, Robert E. MacLaren)....Pages 289-303
Visual Acuity Testing Before and After Intravitreal Injection of rAAV2-ND4 in Patients (Bin Li, Chenmian Wu)....Pages 305-311
Recording and Analysis of the Human Clinical Electroretinogram (Mathieu Gauvin, Allison L. Dorfman, Pierre Lachapelle)....Pages 313-325
Recording and Analysis of Goldmann Kinetic Visual Fields (Mays Talib, Gislin Dagnelie, Camiel J. F. Boon)....Pages 327-338
Measuring Central Retinal Sensitivity Using Microperimetry (Mays Talib, Jasleen K. Jolly, Camiel J. F. Boon)....Pages 339-349
Inspection of the Human Retina by Optical Coherence Tomography (Thomas Theelen, Michel M. Teussink)....Pages 351-358
Vector Shedding and Immunogenicity Sampling for Retinal Gene Therapy (Alun R. Barnard, Anna N. Rudenko, Robert E. MacLaren)....Pages 359-371
Back Matter ....Pages 373-380
β¦ Subjects
Human Genetics
π SIMILAR VOLUMES
<span>This second edition volume expands on the previous edition with updated techniques and discussions on topics such as gene suppression, editing, and reprogramming; cardiac gene therapy vectors and promoters; cardiac gene delivery methods; pulmonary hypertension; and patient screening and measur
<p>This detailed volume explores the methods used for most of the recent approaches to suicide gene therapy of cancer, which exploits promoters that are specific to cancer cells, thereby ensuring (or greatly increasing the likelihood) that the therapeutic gene is expressed only in cancer cells. The
<p>This detailed book provides methodological information on cardiac gene delivery, from classic to state-of-the-art technologies and techniques. Efficient, cardiac-specific, and safe vectors, as well as refined vector delivery methods, are key for successful cardiac gene transfer and eventually for
<p><P>Despite various difficulties, the field of gene therapy, particularly with regard to cancer, has accumulated a tremendous amount of vital pre-clinical and clinical data. <EM>Gene Therapy of Cancer: Methods and Protocols, Second Edition</EM> fully updates the first edition with expert coverage
<p><p>The emerging field of prenatal gene therapy is founded on scientific and technical advances in fetal medicine, molecular biology and gene therapy. This preclinical research subject aims at applying gene therapy during pregnancy for the prevention of human diseases caused by early onset congeni